MetaADEDB 2.0 @ LMMD
Yohimbine
(BLGXFZZNTVWLAY-SCYLSFHTSA-N)
Structure
SMILES
COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
G04BE04
Molecular Formula:
C21H26N2O3
Molecular Weight:
354.443
Log P:
2.5850
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
65.56
CAS Number(s):
146-48-5; 37247-87-3
Synonym(s)
1.
Yohimbine
2.
Rauwolscine
3.
Aphrodine Hydrochloride
4.
Aphrodyne
5.
Corynanthine
6.
Corynanthine Tartrate
7.
Pluriviron
8.
Rauhimbine
9.
Yocon
10.
Yohimbin Spiegel
11.
Yohimbine Houdé
12.
Yohimbine Hydrochloride
13.
Yohimex
14.
Hydrochloride, Aphrodine
15.
Hydrochloride, Yohimbine
16.
Tartrate, Corynanthine
External Link(s)
MeSHD015016
PubChem Compound8969
BindingDB50203564
50013515
ChEBI10093
CHEMBLCHEMBL15245
DrugBankDB01392
DrugCentral3659
IUPHAR/BPS Guide to PHARMACOLOGY102
KEGGcpd:C09256
dr:D08685
Therapeutic Target DatabaseD0H4JM
ZINC3860825
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Akathisia, Drug-Induced3372705CTD
2Alcoholic Intoxication7617798CTD
3Amnesia15265636
20064624
CTD
4Anxiety Disorders

View details

CTD
5Bipolar Disorder6091464CTD
6Bone Resorption27028940CTD
7Bradycardia

View details

CTD
8Cartilage Diseases27028940CTD
9Catalepsy

View details

CTD
10Chemical and Drug Induced Liver Injury2886651CTD
11Chills3153710CTD
12Cocaine-Related Disorders14872205
18824018
CTD
13Disorders of Excessive Somnolence8318322CTD
14Drug Eruptions8470320CTD
15Dyskinesia, Drug-Induced8106150
10495035
CTD
16Edema27028940CTD
17Erectile dysfunction

View details

CTD
18Erythema27028940CTD
19Exotropia3153710CTD
20Feeling abnormalCanada Vigilance: 1Canada Vigilance
21HeadacheCanada Vigilance: 1Canada Vigilance
22Hyperalgesia

View details

CTD
23Hyperemia2841874
7949234
CTD
24Hyperglycemia17195055CTD
25Hyperprolactinemia1678730CTD
26Hypokinesia19429072CTD
27Hypotension, Orthostatic

View details

CTD
28Hypotension

View details

CTD
29Inflammation27028940CTD
30MalaiseCanada Vigilance: 1Canada Vigilance
31Mental disorders2594901
19821221
CTD
32Movement Disorders17306893CTD
33Muscle Rigidity3670563CTD
34Myocardial Infarction2350327CTD
35Myocardial Ischemia2429111
3768070
CTD
36Myocardial Reperfusion Injury2350327CTD
37Myoclonus37558CTD
38NauseaCanada Vigilance: 13021082CTD
Canada Vigilance
39Neurobehavioral Manifestations499336CTD
40Obesity2877928CTD
41Opioid-Related Disorders11955464CTD
42PalpitationsCanada Vigilance: 1Canada Vigilance
43Panic Disorder

View details

CTD
44Polyuria3505923CTD
45Reflex, Abnormal20394767CTD
46Renal Insufficiency8470320CTD
47Seizures

View details

CTD
48Substance Withdrawal Syndrome11955464CTD
49Substance-Related Disorders3153710CTD
50Tachycardia, Ventricular8720421
17852790
CTD
51Tachycardia

View details

CTD
52TremorCanada Vigilance: 1

View details

CTD
Canada Vigilance
53Ventricular Fibrillation2350327
8720421
CTD
54Vomiting19640235CTD
55Xerostomia9272401CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.